Smith Mary L.: insider trades.
Smith Mary L. reported 4 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 2 sales ($1.4M), across 1 company.
- Transactions
- 4
- Purchases (P)
- 0
- Sales (S)
- 2
- Companies
- 1
- Name as filed
- Smith Mary L.
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Ptc Therapeutics, Inc. (PTCT) | Director | 4 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-07-09 | Ptc Therapeutics, Inc. | M | 10,000 | $42.95 | 31,813 | Form 4 |
| 2026-07-09 | Ptc Therapeutics, Inc. | M | 5,834 | $42.95 | 27,647 | Form 4 |
| 2026-07-09 | Ptc Therapeutics, Inc. | S | 5,834 | $90 | 21,813 | Form 4 |
| 2026-07-09 | Ptc Therapeutics, Inc. | S | 10,000 | $90 | 21,813 | Form 4 |
Questions
What stock did Smith Mary L. buy or sell?
Smith Mary L. reported 4 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 2 sales ($1.4M), across 1 company.
Is Smith Mary L. the same person as other filers with this name?
This page covers SEC CIK 1866044 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/smith-mary-l-1866044.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.